SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    McGorry PD, McFarlane C, Patton GC et al. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr Scand 1995; 92: 2419.
  • 2
    Miller TJ, McGlashan TH, Rosen JL et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002; 159: 8635.
  • 3
    Yung AR, Phillips LJ, Yuen HP et al. Psychosis prediction: 12-month follow up of a high-risk (‘prodromal’) group. Schizophr Res 2003; 60: 2132.
  • 4
    Yung AR, Yuen HP, Berger G et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007; 33: 67381.
  • 5
    Warner R. Problems with early and very early intervention in psychosis. Br J Psychiatry 2005; 48 (Suppl): s1047.
  • 6
    Brewer WJ, Francey SM, Wood SJ et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 2005; 162: 718.
  • 7
    Lencz T, Smith CW, McLaughlin D et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 2006; 59: 86371.
  • 8
    Whyte MC, Brett C, Harrison LK et al. Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry 2006; 59: 7309.
  • 9
    Insel TR. The arrival of preemptive psychiatry. Early Interv Psychiatry 2007; 1: 56.
  • 10
    McGorry PD, Yung AR, Phillips LJ et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 9218.
  • 11
    Amminger G, Schaefer MR, Papageorgiou K et al. Omega-3 fatty acids reduce the risk of early transition to psychosis in ultra-high risk individuals: a double-blind randomized placebo-controlled treatment study. Schizophr Bull 2007; 33: 41819.
  • 12
    Morrison AP, French P, Parker S et al. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 2007; 33: 6827.
  • 13
    Larsen TK, Melle I, Auestad B et al. Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull 2006; 32: 75864.
  • 14
    Craig TKJ, Garety P, Power P et al. The Lambeth Early Onset (LEO) Team: randomized controlled trial of the effectiveness of specialized care for early psychosis. BMJ 2004; 329: 1067.
  • 15
    Thorup A, Petersen L, Jeppesen P et al. Integrated treatment ameliorates negative symptoms in first episode psychosis – results from the Danish OPUS trial. Schizophr Res 2005; 79: 95105.
  • 16
    Nordentoft M, Thorup A, Petersen L et al. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res 2006; 83: 2940.
  • 17
    Wright A, McGorry PD, Harris MG, Jorm AF, Pennell K. Development and evaluation of a youth mental health community awareness campaign – the compass strategy. BMC Public Health 2006; 6: 215.